glp 1 and prediabetes GLP-1 for Diabetes vs GLP-1 for Weight Loss: What's Changing for Patients Pharmacies? Metabolic Alteration Bridging the Prediabetic

The Medicines and Healthcare products Regulatory Agency (MHRA) has warned healthcare professionals to be aware of the potential risk of pulmonary aspiration in patients using glucagon-like peptide-1 (GLP-1) or dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1 RAs), who undergo surgery or procedures with general anaesthesia or deep sedation

No injections

Discover medical weight loss with proven medications, tailored plans, and expert guidance for lasting results

Our goal in our weight loss clinics offerings is to revitalize weight loss, improve quality of life and promote longevity.

Build sustainable habits for nutrition, mindset, and long-term success beyond medication.

CivicScience offers insights into the impact of cost, side effects & trends in GLP-1 usage.